PT1070711E - Derivados de pirrole substituidos com heteroarilo sua preparacao e suas utilizacoes terapeuticas - Google Patents
Derivados de pirrole substituidos com heteroarilo sua preparacao e suas utilizacoes terapeuticasInfo
- Publication number
- PT1070711E PT1070711E PT00306196T PT00306196T PT1070711E PT 1070711 E PT1070711 E PT 1070711E PT 00306196 T PT00306196 T PT 00306196T PT 00306196 T PT00306196 T PT 00306196T PT 1070711 E PT1070711 E PT 1070711E
- Authority
- PT
- Portugal
- Prior art keywords
- utilizations
- heteroaryl
- therapeutic
- preparation
- derivatives substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20549199 | 1999-07-21 | ||
| JP36967899 | 1999-12-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1070711E true PT1070711E (pt) | 2004-06-30 |
Family
ID=26515088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00306196T PT1070711E (pt) | 1999-07-21 | 2000-07-20 | Derivados de pirrole substituidos com heteroarilo sua preparacao e suas utilizacoes terapeuticas |
Country Status (22)
| Country | Link |
|---|---|
| EP (2) | EP1070711B1 (pt) |
| KR (2) | KR100776958B1 (pt) |
| CN (1) | CN1294129C (pt) |
| AR (1) | AR024904A1 (pt) |
| AT (1) | ATE264319T1 (pt) |
| AU (1) | AU773453B2 (pt) |
| BR (1) | BR0004534A (pt) |
| CA (1) | CA2314373A1 (pt) |
| DE (1) | DE60009804T2 (pt) |
| DK (1) | DK1070711T3 (pt) |
| ES (1) | ES2216826T3 (pt) |
| HK (2) | HK1033671A1 (pt) |
| HU (1) | HUP0002846A2 (pt) |
| ID (1) | ID26611A (pt) |
| IL (1) | IL137365A0 (pt) |
| MX (1) | MXPA00007199A (pt) |
| NO (1) | NO20003734L (pt) |
| NZ (1) | NZ505924A (pt) |
| PL (1) | PL341620A1 (pt) |
| PT (1) | PT1070711E (pt) |
| TR (1) | TR200002120A3 (pt) |
| TW (1) | TWI259834B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ105499A0 (en) | 1999-06-18 | 1999-07-08 | Biota Scientific Management Pty Ltd | Antiviral agents |
| US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| EP1352906A4 (en) * | 2001-01-18 | 2004-06-16 | Sankyo Co | COMPOSITIONS FOR PREVENTION OR TREATMENT OF LIVER DISEASES |
| WO2002057255A1 (fr) * | 2001-01-22 | 2002-07-25 | Sankyo Company, Limited | Derives du pyrrole substitues en 4 ou 5 |
| EG23054A (en) * | 2001-01-22 | 2004-02-29 | Sankyo Co | Pyrrole derivatives their preparation and their therapeutic uses |
| WO2002057265A1 (fr) | 2001-01-22 | 2002-07-25 | Sankyo Company, Limited | Composes substitues avec des groupes amines bicycliques |
| EP1364949A4 (en) * | 2001-02-02 | 2005-11-23 | Takeda Pharmaceutical | INHIBITOR OF JNK |
| WO2002080974A1 (fr) * | 2001-04-04 | 2002-10-17 | Sankyo Company, Limited | Utilisation medicale d'inhibiteur de production de cytokine |
| WO2002094267A1 (fr) * | 2001-05-24 | 2002-11-28 | Sankyo Company, Limited | Preparation pharmaceutique pour prevenir ou traiter l'arthrite |
| WO2003015781A1 (fr) * | 2001-08-15 | 2003-02-27 | Sankyo Company, Limited | Nouvelles compositions pharmaceutiques antidiabetiques |
| WO2004009592A1 (ja) * | 2002-07-19 | 2004-01-29 | Sankyo Company, Limited | 二環性不飽和３級アミン化合物 |
| US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
| WO2013049559A1 (en) * | 2011-09-30 | 2013-04-04 | Endo Pharmaceuticals Inc. | Pyridine derivatives |
| EP2871179A4 (en) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
| US5792778A (en) * | 1995-08-10 | 1998-08-11 | Merck & Co., Inc. | 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| JP3294616B2 (ja) * | 1995-08-10 | 2002-06-24 | メルク エンド カンパニー インコーポレーテッド | ２−置換アリールピロール、このような化合物を含む組成物及び使用方法 |
-
2000
- 2000-07-18 IL IL13736500A patent/IL137365A0/xx unknown
- 2000-07-20 DE DE60009804T patent/DE60009804T2/de not_active Expired - Fee Related
- 2000-07-20 EP EP00306196A patent/EP1070711B1/en not_active Expired - Lifetime
- 2000-07-20 CA CA002314373A patent/CA2314373A1/en not_active Abandoned
- 2000-07-20 NO NO20003734A patent/NO20003734L/no not_active Application Discontinuation
- 2000-07-20 PT PT00306196T patent/PT1070711E/pt unknown
- 2000-07-20 DK DK00306196T patent/DK1070711T3/da active
- 2000-07-20 AT AT00306196T patent/ATE264319T1/de not_active IP Right Cessation
- 2000-07-20 TW TW089114563A patent/TWI259834B/zh not_active IP Right Cessation
- 2000-07-20 EP EP02011912A patent/EP1243589A1/en not_active Withdrawn
- 2000-07-20 ES ES00306196T patent/ES2216826T3/es not_active Expired - Lifetime
- 2000-07-21 NZ NZ505924A patent/NZ505924A/en unknown
- 2000-07-21 AR ARP000103779A patent/AR024904A1/es unknown
- 2000-07-21 KR KR1020000042064A patent/KR100776958B1/ko not_active IP Right Cessation
- 2000-07-21 PL PL00341620A patent/PL341620A1/xx unknown
- 2000-07-21 CN CNB001313037A patent/CN1294129C/zh not_active Expired - Fee Related
- 2000-07-21 TR TR2000/02120A patent/TR200002120A3/tr unknown
- 2000-07-21 MX MXPA00007199A patent/MXPA00007199A/es unknown
- 2000-07-21 BR BR0004534-9A patent/BR0004534A/pt not_active Application Discontinuation
- 2000-07-21 HU HU0002846A patent/HUP0002846A2/hu unknown
- 2000-07-21 AU AU48755/00A patent/AU773453B2/en not_active Ceased
- 2000-07-21 ID IDP20000612A patent/ID26611A/id unknown
-
2001
- 2001-06-19 HK HK01104212A patent/HK1033671A1/xx not_active IP Right Cessation
- 2001-06-19 HK HK02108839.6A patent/HK1047587A1/zh unknown
-
2007
- 2007-01-22 KR KR1020070006711A patent/KR20070026708A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60009804T2 (de) | 2005-01-05 |
| CN1294129C (zh) | 2007-01-10 |
| TWI259834B (en) | 2006-08-11 |
| DE60009804D1 (de) | 2004-05-19 |
| HUP0002846A2 (hu) | 2002-07-29 |
| ID26611A (id) | 2001-01-25 |
| HU0002846D0 (en) | 2000-09-28 |
| EP1243589A1 (en) | 2002-09-25 |
| KR20010049843A (ko) | 2001-06-15 |
| NZ505924A (en) | 2001-11-30 |
| EP1070711A2 (en) | 2001-01-24 |
| TR200002120A2 (tr) | 2001-06-21 |
| NO20003734D0 (no) | 2000-07-20 |
| ES2216826T3 (es) | 2004-11-01 |
| ATE264319T1 (de) | 2004-04-15 |
| CN1295069A (zh) | 2001-05-16 |
| CA2314373A1 (en) | 2001-01-21 |
| DK1070711T3 (da) | 2004-05-10 |
| NO20003734L (no) | 2001-01-22 |
| MXPA00007199A (es) | 2003-03-12 |
| HK1047587A1 (zh) | 2003-02-28 |
| EP1070711B1 (en) | 2004-04-14 |
| KR100776958B1 (ko) | 2007-11-27 |
| AU773453B2 (en) | 2004-05-27 |
| KR20070026708A (ko) | 2007-03-08 |
| EP1070711A3 (en) | 2001-01-31 |
| PL341620A1 (en) | 2001-01-29 |
| HK1033671A1 (en) | 2001-09-14 |
| BR0004534A (pt) | 2001-02-28 |
| TR200002120A3 (tr) | 2001-06-21 |
| AU4875500A (en) | 2001-02-01 |
| AR024904A1 (es) | 2002-10-30 |
| IL137365A0 (en) | 2001-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1177178E (pt) | Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao | |
| PT1189895E (pt) | Derivados de tiazole e oxazole e sua utilizacao farmaceutica | |
| EE04565B1 (et) | Adamantaani derivaadid, nende saamine ja kasutamine | |
| NO20021400D0 (no) | Terapeutiske konazolinderivater | |
| NO20015175L (no) | Farmasöytisk sammensetning | |
| PT1307457E (pt) | Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos | |
| BR0016395B1 (pt) | Derivados de adamantano | |
| PT911340E (pt) | Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos | |
| PT1119557E (pt) | Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos | |
| IS6040A (is) | Valdekoxib efnablöndur | |
| DK1128831T3 (da) | Farmaceutisk moxifloxacinpræparat | |
| PT1173187E (pt) | Preparacoes combinadas compreendendo derivados de antraciclina | |
| DK1466615T3 (da) | Farmaceutisk præparat | |
| EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| PT1070711E (pt) | Derivados de pirrole substituidos com heteroarilo sua preparacao e suas utilizacoes terapeuticas | |
| EE200200150A (et) | Preparaat | |
| PT1230230E (pt) | Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico | |
| PT1210085E (pt) | Solucoes farmaceuticas de levosimendano | |
| NO20022606D0 (no) | Farmasöytiske kombinasjoner | |
| PT1043307E (pt) | Derivados de 3-amino-3-arilpropan-1-ol sua producao e utilizacao | |
| NO20010089D0 (no) | Farmasöytisk levotyroksinpreparat | |
| DE60032898D1 (de) | Arylthiazolidindion- und aryloxazolidinderivate | |
| ATE241622T1 (de) | Thiazolidindion-derivate als antidiabetika | |
| FI4488U1 (fi) | Farmaseuttinen koostumus | |
| AR025867A1 (es) | Formulacion portasdora farmaceutica |